Ctt Pharmaceutical Holdings CTTH Insider Ownership

OTC CTTH
$0.05 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Insider Holdings by Owner

16.40Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
103.98%
▲+10.05% pp QoQ
Shares Held by Insiders
16.40Mn
filed for Sep 2026
▲+10.69% QoQ
Shares Outstanding
15.77Mn
15,768,949 shares
Direct Holdings
16.40Mn
Indirect: 0
Net Shares Traded (QoQ)
+1.58Mn
net buying in Sep 2026
Insiders Holding Shares
1
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of September 29, 2026, Ctt Pharmaceutical Holdings's top three insider holders are Pharmaceutical Holdings, Inc. Ctt (Ceo, 9.43Mn shares), Pharmaceutical Holdings, Inc. Ctt (Ceo, 6.97Mn shares).

Form 4 Holdings

Insiders Holding CTTH

Insiders 1
Shares held 16.40Mn
Of outstanding 103.98%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Pharmaceutical Holdings, Inc. Ctt Ceo 16,396,812 0 16,396,812 100.0% 28 Sep, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

78 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
28 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,400 $0.06 $187 9,429,956 Direct
22 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 10,100 $0.05 $455 1,056,800 Direct
10 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,500 $0.05 $175 9,400,556 Direct
04 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 9,800 $0.05 $479 9,397,056 Direct
02 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,000 $0.05 $147 9,387,256 Direct
31 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,500 $0.05 $172 9,384,256 Direct
24 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 2,100 $0.06 $116 9,360,756 Direct
20 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 11,500 $0.05 $518 9,378,656 Direct
19 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 10,000 $0.06 $590 9,365,456 Direct
14 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 1,800 $0.06 $112 9,355,456 Direct
07 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 7,700 $0.07 $501 9,353,656 Direct
17 Dec, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 8,300 $0.06 $457 7,845,956 Direct
20 Nov, 2025 Pharmaceutical Holdings, Inc. Ctt Director Acquired P 200,000 $0.04 $8.00K 3,734,003 Direct
20 Nov, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 62,900 $0.04 $2.52K 7,837,656 Direct
31 Oct, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 7,000 $0.06 $420 7,774,756 Direct
23 Sep, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 6,815 $0.06 $409 7,767,756 Direct
01 Aug, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired A 750,000 $0.04 $30.00K 7,716,856 Direct
02 Aug, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 44,085 $0.05 $1.98K 7,760,941 Direct
01 Aug, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 15,800 $0.04 $553 6,966,856 Direct
08 Jul, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 8,000 $0.03 $240 6,951,056 Direct